← Back to Search

Behavioural Intervention

AI-Assisted Treatment Planning for Gastrointestinal Cancer

N/A

Recruiting

Led By Di Dong, PhD

Research Sponsored by Chinese Academy of Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 years

Awards & highlights

Study Summary

This trial will assess the effectiveness of using AI to create personalized treatment plans for GI cancer patients.

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of gastrointestinal cancer, specifically gastric or colorectal cancer. They must be treated at the participating hospitals and have detailed medical records available. It's not open to those treated across multiple hospitals or with different types of cancers.Check my eligibility

What is being tested?

The study is testing how well ChatGPT can help doctors create treatment plans for gastrointestinal cancers compared to standard clinician-directed methods. It will use both past and current patient data to assess the effectiveness.See study design

What are the potential side effects?

Since this trial involves treatment planning rather than direct medical interventions, there are no side effects from drugs being tested. However, differences in treatment outcomes may occur based on the recommendations provided.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Influence Rate of ChatGPT on Treatment Plans

Secondary outcome measures

3-year Progression-Free Survival (PFS) Rate

Other outcome measures

5-year Overall Survival (OS) Rate

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: GPT-Assisted GroupExperimental Treatment1 Intervention

In this arm, participants receive treatment plans from clinicians with the assistance of ChatGPT.

Group II: Control groupActive Control1 Intervention

In this arm, participants receive treatment plans directly from clinicians without the assistance of ChatGPT.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Peking University Cancer Hospital (Inner Mongolia Campus)UNKNOWN

San Raffaele University Hospital, ItalyOTHER

29 Previous Clinical Trials

11,545 Total Patients Enrolled

University Hospital Magdeburg, GermanyUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many sites are under the supervision of this clinical trial?

"In addition to Jiangmen Central Hospital in Guangdong, The Fifth Affiliated Hospital of Sun Yat-sen University in Zhuhai, and Zhuhai People's Hospital in Hohhot, this trial is also enrolling patients from seven other medical sites."

Answered by AI

How many participants are being enlisted in this experiment?

"Affirmative. Data hosted on clinicaltrials.gov indicates that this trial, which was initially uploaded on August 29th 2023, is actively recruiting participants. 400 individuals are required to be enlisted from seven different medical centres."

Answered by AI

Does this trial accept new enrollees at the present time?

"Affirmative. The data hosted on clinicaltrials.gov verifies that this trial, which was initially posted on August 29th 2023 is actively recruiting participants. Around 400 people are required to be enrolled from 7 different medical centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models

Di Dong 2023. "Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06002425.